Lineage Cell Therapeutics, Inc. (LCTX): Gross Profit
Older than the company's other figures. The latest Gross Profit is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$8.27M
Year ended 2023-12-31
+79.1%
3-year compound annual growth
+12.0%
5-year compound annual growth
+8.6%
10-year compound annual growth
| Period ended | Gross Profit | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | $8.27M | -40.8% | 2024-03-07, From 2023-01-01 |
| 2022-12-31 | $13.97M | +379.4% | 2024-03-07, From 2022-01-01 |
| 2021-12-31 | $2.92M | +102.3% | 2023-03-09, From 2021-01-01 |
| 2020-12-31 | $1.44M | -53.6% | 2022-03-10, From 2020-01-01 |
| 2019-12-31 | $3.10M | -33.8% | 2021-03-11, From 2019-01-01 |
| 2018-12-31 | $4.69M | +42.4% | 2020-03-12, From 2018-01-01 |
| 2017-12-31 | $3.29M | -40.9% | 2019-03-14, From 2017-01-01 |
| 2016-12-31 | $5.57M | -6.1% | 2018-03-15, From 2016-01-01 |
| 2015-12-31 | $5.93M | +34.5% | 2018-03-15, From 2015-01-01 |
| 2014-12-31 | $4.41M | +21.0% | 2017-03-16, From 2014-01-01 |
| 2013-12-31 | $3.64M | +4.6% | 2016-03-15, From 2013-01-01 |
| 2012-12-31 | $3.48M | -20.1% | 2015-03-11, From 2012-01-01 |
| 2011-12-31 | $4.35M | +18.3% | 2014-03-17, From 2011-01-01 |
| 2010-12-31 | $3.68M | n/a | 2013-03-18, From 2010-01-01 |